Abstract

Lisinopril 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2020 - Volume 24, Number 4

Page(s): 318

Download in electronic PDF format for $75
  • Lisinopril 1 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Lisinopril 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • lisinopril
  • long-acting angiotensin-converting enzyme inhibitor
  • ACE inhibitor
  • antihypertensive agent
  • hypertension
  • high blood pressure

Related Categories

  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2020
Pg. 318
Lisinopril 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 386
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 302
Lisinopril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 148
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
May/Jun 2006
Pg. 227
Quinapril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 221
Enalapril Maleate 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 336-338
Stability of Captopril in SyrSPend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Nov/Dec 2019
Pg. 494
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
May/Jun 2007
Pg. 242
Benazepril 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 56
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 491
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 147
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr